FdaApplication

ANDA 091305

Back to search

Identifiers

Properties

PropertyValue
applicant_nameINVAGEN PHARMACEUTICALS INC
application_typeANDA
approval_date2011-08-24

Products (3)

ProductActive ingredientStrengthDosage form
NAPROXENNAPROXEN375MGTABLET;ORAL
NAPROXENNAPROXEN500MGTABLET;ORAL
NAPROXENNAPROXEN250MGTABLET;ORAL

3 products